Genzyme to Build New Biomanufacturing Plant to Support Growth of Thymoglobulin® Facility Expected to be Among First Manufacturing Sites in France To Gain High Environmental Quality Certification June ...

Genzyme Corporation (NASDAQ: GENZ) announced today that the FDA informed the company late Thursday that it will re-inspect the company's Allston Landing manufacturing facility. The re-inspection is a ...

Cerezyme production has been bumped up, while initial distributions of Fabrazyme will be lower than expected. Genzyme reports that all six bioreactors at its Allston Landing, MA, manufacturing ...

(Refiles to insert dropped word "Cerezyme" in paragraph 15) * No quick answers to Genzyme's manufacturing woes * Competitors work to upgrade plants, reduce risk By Toni Clarke BOSTON, Oct 20 (Reuters) ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corp. (NASDAQ: GENZ) today announced that it will build an additional manufacturing plant in Geel, Belgium, to support the long-term growth of Myozyme® and ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that the Food and Drug Administration (FDA) has approved its manufacturing plant in ...

Genzyme’s bad news could be Actelion’s good news. Contamination concerns caused Cambridge, Mass.-based Genzyme Corp. to temporarily shutdown a Massachusetts plant that makes its Gaucher’s disease drug ...

The U.S. Food and Drug Administration enforcement action against Genzyme Corp. will result in a third drug shortage for the company, restricting patient access to its thyroid cancer medicine. The U.S.

Sanofi Genzyme will lay off 130 workers this week at its manufacturing plant in Boston in an effort to reduce costs and simplify operations, according to the Boston Globe. The layoffs will only affect ...

Cambridge-based Genzyme Corp. said it has begun shipping new vials of its Cerezyme drug manufactured at the Allston plant shut down earlier this year because of contamination. The company said initial ...

NEW YORK (Reuters) - Genzyme Corp has halted production of two of its top-selling drugs after detecting a virus at a Boston plant that U.S. regulators had already cited for deficiencies. Genzyme, ...